Glucocorticoids - New Recognition of Our Familiar Friend 2012
DOI: 10.5772/51467
|View full text |Cite
|
Sign up to set email alerts
|

Molecular Mechanisms Conferring Resistance/Sensitivity to Glucocorticoid-Induced Apoptosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2017
2017
2020
2020

Publication Types

Select...
2

Relationship

2
0

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 148 publications
(176 reference statements)
0
2
0
Order By: Relevance
“…Necrosome formation via stimulation of TRAIL/TNF activates RIPK3 which interacts with enzymes regulating glycolytic flux and glutaminolysis [ 68 ]. Reactive oxygen species ultimately form, whilst redox status is important in determining sensitivity to microenvironment and chemotherapy [ 35 , 67 69 ]. RIPK1 substrates are yet to be identified as are factors necessary for cell death induction through necroptosis or apoptosis [ 55 ].…”
Section: Discussionmentioning
confidence: 99%
“…Necrosome formation via stimulation of TRAIL/TNF activates RIPK3 which interacts with enzymes regulating glycolytic flux and glutaminolysis [ 68 ]. Reactive oxygen species ultimately form, whilst redox status is important in determining sensitivity to microenvironment and chemotherapy [ 35 , 67 69 ]. RIPK1 substrates are yet to be identified as are factors necessary for cell death induction through necroptosis or apoptosis [ 55 ].…”
Section: Discussionmentioning
confidence: 99%
“…Several gene mutations and hazardous environmental factors (including radiation and toxic chemical exposure) are associated with ALL in children (4,5). Factors affecting the Endoplasmic reticulum stress, unfolded protein response and autophagy contribute to resistance to glucocorticoid treatment in human acute lymphoblastic leukaemia cells development of resistance to ALL treatment include genetic variability in xenobiotic metabolism (6), prevalence of a GC receptor (GR)β splicing variant (7), upregulation of the antiapoptotic Bcl-2 family proteins (8), differential phosphorylation of GR in dex-induced apoptosis-resistant vs. sensitive ALL cells (9), alterations in dNA repair pathways (10) and cell cycle checkpoint defects (11).…”
Section: Introductionmentioning
confidence: 99%